Jacob M. Appel, M.D., J.D. Nearly a year has elapsed since the University of Toronto established the world’s first anti-psychiatry scholarship in November 2016, and now that the dust has settled, the moment seems opportune to consider the merit of the fellowship and the state of antipsychiatry more generally. The fellowship itself, a grant of […]
Leo Sher, M.D. Our research article, “CSF monoamine metabolites and lethality of suicide attempts in depressed patients with alcohol dependence” was published 10 years ago in a 2007 issue of “European Neuropsychopharmacology” (1). Monoaminergic abnormalities have been implicated in the pathophysiology of depression, alcohol use disorder, and suicidal behavior. We examined the relationship of cerebrospinal […]
Leo Sher, M.D. A research report, “Mushroom consumption and incident dementia in elderly Japanese: The Ohsaki Cohort 2006 Study” was published in the July 2017 issue of the Journal of the American Geriatrics Society (1). The authors studied the relationship between mushroom consumption and incident dementia in a population of elderly Japanese individuals. 13,230 individuals […]
Nestor Szerman, Jose Martinez-Raga, Ruben Baler, Carlos Roncero, Pablo Vega, Ignacio Basurte, Lara Grau-López, Marta Torrens, Miquel Casas, Pedro Ruiz The World Association on Dual Disorders, the WPA Section on Dual Disorders and the Spanish Society of Dual Disorders have joined forces to clarify that: Addiction is a Mental Disorder, not a voluntary, self-indulgent act […]
Leo Sher, M.D. Our research report, “Positron emission tomography study of regional brain metabolic responses to a serotonergic challenge in major depressive disorder with and without comorbid lifetime alcohol dependence” was published in the September 2007 issue of European Neuropsychopharmacology (1). It was the first study comparing the regional glucose metabolic rate (rCMRglu) responses to […]
Sohaib Khaleel Mohammed, M.D., Angeline Prabhu, M.D., Samreen Fathima, M.D., Bilal Abaid, M.D., Steven Lippmann, M.D. Introduction Misuse of prescription opioids is a public health issue. In the United States (US), over two million adults annually abuse such drugs (1). By 2008, approximately 14 million people aged 12 years or older used oxycodone in their […]
Jyothi Chitekela, M.D., Angeline Prabhu, M.D., Bilal Abaid, M.D., Steven Lippmann, M.D. “Is my patient really sick?”; you might have asked yourself this question! Such a circumstance may occur while assessing patients who present with Munchausen’s Syndrome. This illness is often a difficult diagnosis and/or a vexing differential. The condition was identified during the 1700s, […]
Leo Sher, M.D. A research paper, “Lithium levels in the public drinking water supply and risk of suicide: A pilot study” is published in the September, 2017 issue of the Journal of Trace Elements in Medicine and Biology (1). We examined a relation between lithium levels in the drinking water and suicide rates in Lithuania. […]
Ruma Mian, M.D. Introduction Depression is not only the most common mental illness, it’s also one of the most tenacious. Epidemiologically, 50 percent of the population that experiences one major depressive episode will relapse and 80 percent will relapse after experiencing a second episode (1). Although anti-depressive medications may benefit some, a shocking number find […]
Shivani Naik, M.D., Murali K.Kolikonda, M.D., Steven Lippmann, M.D. Parkinson’s disease (PD) is well known by its cardinal motor symptoms of tremor, bradykinesia, rigidity, and postural or gait instability. Parkinsonism without tremor is frequently misdiagnosed. That PD can also induce a pain syndrome is less widely recognized. Parkinsonian pain is prevalent in 40-85% of PD […]
